S.M. Keller

944 total citations
30 papers, 725 citations indexed

About

S.M. Keller is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, S.M. Keller has authored 30 papers receiving a total of 725 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 13 papers in Oncology and 12 papers in Surgery. Recurrent topics in S.M. Keller's work include Lung Cancer Treatments and Mutations (13 papers), Lung Cancer Diagnosis and Treatment (9 papers) and Cancer Immunotherapy and Biomarkers (8 papers). S.M. Keller is often cited by papers focused on Lung Cancer Treatments and Mutations (13 papers), Lung Cancer Diagnosis and Treatment (9 papers) and Cancer Immunotherapy and Biomarkers (8 papers). S.M. Keller collaborates with scholars based in United States, Spain and France. S.M. Keller's co-authors include Janet Whatley, Bruce A. McDonald, J M McDermott, Blackburn Gl, Martin S. Wolfe, Jill M. Siegfried, Joseph R. Testa, Takashi Taguchi, Joan H. Schiller and S. Adak and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Clinical Nutrition and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

S.M. Keller

28 papers receiving 692 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S.M. Keller United States 11 319 186 127 108 95 30 725
Mei Lan China 11 73 0.2× 65 0.3× 80 0.6× 115 1.1× 139 1.5× 35 510
Mingjun Sun China 16 102 0.3× 209 1.1× 9 0.1× 76 0.7× 204 2.1× 39 871
Qing Gu China 13 92 0.3× 39 0.2× 161 1.3× 56 0.5× 139 1.5× 21 619
Megumi Kobayashi Japan 15 29 0.1× 36 0.2× 137 1.1× 159 1.5× 207 2.2× 39 566
H Dyggve Denmark 14 59 0.2× 27 0.1× 39 0.3× 62 0.6× 120 1.3× 46 684
Mary Lee Fitzsimmons United States 9 18 0.1× 185 1.0× 48 0.4× 57 0.5× 58 0.6× 16 514
Annie On On Chan Hong Kong 9 88 0.3× 88 0.5× 10 0.1× 180 1.7× 135 1.4× 12 454
KirtikumarD Modi India 9 41 0.1× 37 0.2× 17 0.1× 122 1.1× 88 0.9× 17 480
Sarah M. Mitchell New Zealand 14 91 0.3× 139 0.7× 7 0.1× 25 0.2× 212 2.2× 29 787
Huiying Chen China 13 30 0.1× 51 0.3× 41 0.3× 47 0.4× 155 1.6× 40 515

Countries citing papers authored by S.M. Keller

Since Specialization
Citations

This map shows the geographic impact of S.M. Keller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.M. Keller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.M. Keller more than expected).

Fields of papers citing papers by S.M. Keller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S.M. Keller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.M. Keller. The network helps show where S.M. Keller may publish in the future.

Co-authorship network of co-authors of S.M. Keller

This figure shows the co-authorship network connecting the top 25 collaborators of S.M. Keller. A scholar is included among the top collaborators of S.M. Keller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S.M. Keller. S.M. Keller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wakelee, Heather A., Shugeng Gao, Moïshe Liberman, et al.. (2025). LBA67 Perioperative pembrolizumab in early-stage non-small- cell lung cancer (NSCLC): 5-year follow-up from KEYNOTE- 671. Annals of Oncology. 36. S1607–S1608.
2.
Graaf, Winette T.A. van der, S.M. Keller, Jean‐Yves Blay, et al.. (2025). Overcoming the barriers to treatment of rare cancer patients in the era of precision oncology: A call to action. Cancer Treatment Reviews. 140. 103013–103013.
3.
4.
Besse, Benjamin, Libor Havel, Solange Peters, et al.. (2023). 120MO Adjuvant pembrolizumab versus placebo for early-stage NSCLC after resection and optional chemotherapy: Updated results from PEARLS/KEYNOTE-091. Immuno-Oncology Technology. 20. 100592–100592. 7 indexed citations
5.
Gao, Shugeng, Moïshe Liberman, Terufumi Kato, et al.. (2023). LBA56 Overall survival in the KEYNOTE-671 study of perioperative pembrolizumab for early-stage non-small-cell lung cancer (NSCLC). Annals of Oncology. 34. S1297–S1298. 51 indexed citations
6.
7.
Peters, Solange, Sandrine Marréaud, Urania Dafni, et al.. (2022). 930MO PD-L1 expression and outcomes of pembrolizumab and placebo in completely resected stage IB-IIIA NSCLC: Subgroup analysis of PEARLS/KEYNOTE-091. Annals of Oncology. 33. S971–S972. 7 indexed citations
8.
Reck, M., Nikolaj Frost, Dariusz M. Kowalski, et al.. (2021). OA02.03 Pembrolizumab Plus Platinum Chemotherapy and Radiotherapy in Unresectable, Locally Advanced, Stage III NSCLC: KEYNOTE-799. Journal of Thoracic Oncology. 16(3). S103–S104. 3 indexed citations
9.
Keller, S.M., et al.. (2015). (ii) Principles of the surgical management of bone tumours. Orthopaedics and Trauma. 29(3). 160–162. 2 indexed citations
10.
11.
Kleinberg, Lawrence, et al.. (2006). 143. International Journal of Radiation Oncology*Biology*Physics. 66(3). S80–S80. 4 indexed citations
12.
Keller, S.M., Márk Vangel, S. Adak, et al.. (2002). The influence of gender on survival and tumor recurrence following adjuvant therapy of completely resected stages II and IIIa non-small cell lung cancer. Lung Cancer. 37(3). 303–309. 37 indexed citations
13.
Khandani, Amir H., S.M. Keller, & M. Donald Blaufox. (2002). 18F-fluorodeoxyglucose positron emission tomography: False-positive lung scan. Seminars in Nuclear Medicine. 32(3). 212–213. 3 indexed citations
14.
15.
Gl, Blackburn, et al.. (1997). The effect of aspartame as part of a multidisciplinary weight-control program on short- and long-term control of body weight. American Journal of Clinical Nutrition. 65(2). 409–418. 144 indexed citations
16.
Keller, S.M., et al.. (1997). Gene Flow and Sexual Reproduction in the Wheat Glume Blotch Pathogen Phaeosphaeria nodorum (Anamorph Stagonospora nodorum). Phytopathology. 87(3). 353–358. 83 indexed citations
17.
Sauter, Edward R., et al.. (1995). p53 and disease progression in patients with non-small cell lung cancer. Surgical Oncology. 4(3). 157–161. 4 indexed citations
18.
Keller, S.M., et al.. (1994). Chronic post thoracotomy pain.. PubMed. 35(6 Suppl 1). 161–4. 57 indexed citations
19.
Taguchi, Takashi, et al.. (1993). Recurrent deletions of specific chromosomal sites in 1p, 3p, 6q, and 9p in human malignant mesothelioma.. PubMed. 53(18). 4349–55. 131 indexed citations
20.
Cheraskin, E., et al.. (1960). The Normal Glucose Tolerance Pattern: The Development of Blood Glucose Normality by an Analysis of Oral Symptoms. The Journal of Periodontology. 31(2). 123–137. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mei Lan Breakdown of academic impact, for papers by Mingjun Sun Breakdown of academic impact, for papers by Qing Gu Breakdown of academic impact, for papers by Megumi Kobayashi Breakdown of academic impact, for papers by H Dyggve Breakdown of academic impact, for papers by Mary Lee Fitzsimmons Breakdown of academic impact, for papers by Annie On On Chan Breakdown of academic impact, for papers by KirtikumarD Modi Breakdown of academic impact, for papers by Sarah M. Mitchell Breakdown of academic impact, for papers by Huiying Chen
Rankless by CCL
2026